In the fourth Venture Breakfast series in collaboration with PWC, the panel will be discussing the biotech market, including:
What parts of biotech are still attractive to VC's ?
What is the exit environment like, both IPO's and M&A?
What are key regulatory issues?
What are the pros and cons of foreign trials?
Come join us at Pillsbury Winthrop on January 22, 2008 to discuss and debate with some of the leading VC's.
Moderator: Allison Leopold Tilley, Pillsbury Winthrop
Steve Bengston, PricewaterhouseCoopers
Shelley Chu, Frazier Healthcare's biopharma
Members $20, Non-Member $30, Platinum Pass $0.
Official Website: http://www.sdforum.org/CorporateVenture
Added by FullCalendar on December 23, 2007